Phytochemical profile and biological activities of Bromelia antiacantha extracts.
Kétlin Fernanda RodriguesT C BitencourtJisette G NÚÑezHelana O GarciaB BuhlGustavo L PadilhaEduardo Miranda EthurLucélia HoehneAlessandra N BrunoElisete Maria de FreitasPublished in: Brazilian journal of biology = Revista brasleira de biologia (2022)
Reports from popular medicine usually act as a basis for the development of new drugs from natural compounds with therapeutic actions for serious diseases and prevalence such as cancer. Bromelia antiacantha Bertol. is a species of the Bromeliaceae family, considered an unconventional food plant, found in the south and midwest regions of Brazil. Despite the high nutritional content and pharmacological potential of its fruits, few scientific studies report its biological actions. Thus, this study evaluates the phytochemical profile of aqueous and ethanol extracts obtained from B. antiacantha fruits, as well as their possible antioxidant, antitumor, and cytotoxic activities. The aqueous extract exhibited phenolic compounds and flavonoids, while ethanol extracts indicated the presence of flavonoids and coumarin in their composition, regardless of the region of collection. The ethanolic extract demonstrated a more promising antioxidant effect than the aqueous extract and also induced a significant inhibition in the viability of human cervical cancer cells of the SiHa strain. In addition, treatment with both extracts did not alter the viability of non-tumor cells of the immortalized human keratinocyte lineage (HaCaT). These results bring new data about extracts obtained from a native plant, edible and traditionally used in popular medicine, opening new perspectives for its possible therapeutic application.
Keyphrases
- oxidative stress
- anti inflammatory
- endothelial cells
- ionic liquid
- diabetic rats
- induced pluripotent stem cells
- papillary thyroid
- risk factors
- pluripotent stem cells
- machine learning
- emergency department
- drug induced
- climate change
- risk assessment
- artificial intelligence
- lymph node metastasis
- combination therapy
- case control